In the wake of the COVID-19 pandemic, are there any hypofractionated regimens (without concurrent chemotherapy) that could be utilized for head /neck cancer in a post operative setting?

Topics: Head and Neck Cancers • Radiation Oncology • COVID-19

Answer from: Radiation Oncologist at Academic Institution

A very recent paper by Eric Hall and David Brenner’s group (Shuryak et al., Int J Radiation Oncol Biol Phys 2019) is titled “optimized hypofractionation can markedly improve tumor control and decrease late effects for head and neck cancer”. Using a recently improved model, they con...

Comments

Radiation Oncologist at Radiation Oncology Associates
I thought the 54 Gy/18 fx regimen was very intrigu...

Answer from: Radiation Oncologist at Academic Institution

Agree. 50 Gy at 2.5 Gy per fraction is another option with a long track record.

Related Questions